Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-20-000035
Filing Date
2020-11-05
Accepted
2020-11-05 16:05:39
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20200930.htm   iXBRL 10-Q 1448166
2 EX-31.1 fold-09302020xex311.htm EX-31.1 13157
3 EX-31.2 fold-09302020xex312.htm EX-31.2 13273
4 EX-32.1 fold-09302020xex321.htm EX-32.1 11501
  Complete submission text file 0001178879-20-000035.txt   6504280

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20200930.xsd EX-101.SCH 35995
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20200930_cal.xml EX-101.CAL 85940
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20200930_def.xml EX-101.DEF 207798
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20200930_lab.xml EX-101.LAB 534693
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20200930_pre.xml EX-101.PRE 348967
10 EXTRACTED XBRL INSTANCE DOCUMENT fold-20200930_htm.xml XML 1185868
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 201290407
SIC: 2834 Pharmaceutical Preparations